The incidence, monitoring coverage and clinical characteristics of hydroxychloroquine retinopathy in the United Kingdom.
Yusuf Imran H, Han Ruofan C, Downes Susan M, Sharma Srilakshmi M
UK study found HCQ retinopathy incidence was low (0.04-0.08%), but monitoring coverage was very poor (2.6-5.5%). Monitoring preserved better vision, highlighting its clinical importance despite low uptake.